<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Scala F</submitter><funding>National Center for Advancing Translational Sciences</funding><funding>NCATS NIH HHS</funding><funding>National Institutes of Health (NIH NIMH R01 MH095995 to Fernanda Laezza)</funding><funding>NIMH NIH HHS</funding><funding>Translational Sciences at the University of Texas Medical Branch</funding><funding>Alzheimer&amp;apos;s Association</funding><funding>Università Cattolica</funding><pagination>886-900</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4801354</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>36(2)</volume><pubmed_abstract>Amyloid β-protein (Aβ) pathologies have been linked to dysfunction of excitability in neurons of the hippocampal circuit, but the molecular mechanisms underlying this process are still poorly understood. Here, we applied whole-cell patch-clamp electrophysiology to primary hippocampal neurons and show that intracellular Aβ42 delivery leads to increased spike discharge and action potential broadening through downregulation of A-type K(+) currents. Pharmacologic studies showed that caspases and glycogen synthase kinase 3 (GSK-3) activation are required for these Aβ42-induced effects. Extracellular perfusion and subsequent internalization of Aβ42 increase spike discharge and promote GSK-3-dependent phosphorylation of the Kv4.2 α-subunit, a molecular determinant of A-type K(+) currents, at Ser-</pubmed_abstract><journal>Neurobiology of aging</journal><pubmed_title>Intraneuronal Aβ accumulation induces hippocampal neuron hyperexcitability through A-type K(+) current inhibition mediated by activation of caspases and GSK-3.</pubmed_title><pmcid>PMC4801354</pmcid><funding_grant_id>R01 MH095995</funding_grant_id><funding_grant_id>UL1TR000071</funding_grant_id><funding_grant_id>UL1 TR000071</funding_grant_id><funding_grant_id>NIRG-14-321307</funding_grant_id><pubmed_authors>Scala F</pubmed_authors><pubmed_authors>Spinelli M</pubmed_authors><pubmed_authors>Laezza F</pubmed_authors><pubmed_authors>D'Ascenzo M</pubmed_authors><pubmed_authors>Ripoli C</pubmed_authors><pubmed_authors>Piacentini R</pubmed_authors><pubmed_authors>Grassi C</pubmed_authors><pubmed_authors>Fusco S</pubmed_authors><pubmed_authors>Li Puma DD</pubmed_authors></additional><is_claimable>false</is_claimable><name>Intraneuronal Aβ accumulation induces hippocampal neuron hyperexcitability through A-type K(+) current inhibition mediated by activation of caspases and GSK-3.</name><description>Amyloid β-protein (Aβ) pathologies have been linked to dysfunction of excitability in neurons of the hippocampal circuit, but the molecular mechanisms underlying this process are still poorly understood. Here, we applied whole-cell patch-clamp electrophysiology to primary hippocampal neurons and show that intracellular Aβ42 delivery leads to increased spike discharge and action potential broadening through downregulation of A-type K(+) currents. Pharmacologic studies showed that caspases and glycogen synthase kinase 3 (GSK-3) activation are required for these Aβ42-induced effects. Extracellular perfusion and subsequent internalization of Aβ42 increase spike discharge and promote GSK-3-dependent phosphorylation of the Kv4.2 α-subunit, a molecular determinant of A-type K(+) currents, at Ser-</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Feb</publication><modification>2025-04-26T01:55:45.128Z</modification><creation>2019-03-27T03:09:57Z</creation></dates><accession>S-EPMC4801354</accession><cross_references><pubmed>25541422</pubmed><doi>10.1016/j.neurobiolaging.2014.10.034</doi></cross_references></HashMap>